The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.

Also, it is known that if taken for weight loss, the drug will likely be taken for life. Malhotra said research is still out on whether the same goes for treating sleep apnea.

It isn’t. "Medications like Ozempic lead to weight loss, which helps to improve sleep apnea," explains Brian Wojeck, MD, MPH, an endocrinologist at Yale Medicine in New Haven, Connecticut.

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk and potential applications for addiction treatment.

Bariatric surgeon Jonathan Carter discusses the pros and cons of surgery compared with GLP-1 drugs. For those with severe ...

Results from this study show that there is a direct correlation between the use of anti-obesity medications and testosterone levels,” the study author said.

And as of December 20, Eli Lilly's weight loss drug Zepbound (tirzepetide) has become the first prescription medication FDA-approved to treat obstructive sleep apnea by increasing airflow and ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking the ...

And as of December 20, Eli Lilly’s weight loss drug Zepbound (tirzepetide) has become the first prescription medication FDA-approved to treat obstructive sleep apnea by increasing airflow and ...